| NCT04507763 | Pfizer | Ankylosing Spondylitis | 2020-08-01 | |
| NCT00936065 | Pfizer | Moderate to Severe Psoriasis | 2009-07 | PHASE4 |
| NCT00034060 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Rheumatoid Arthritis|Healthy | 2002-04 | PHASE2 |
| NCT01331837 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-08-02 | PHASE4 |
| NCT00127842 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Psoriatic Arthritis | 2005-08 | PHASE4 |
| NCT00422227 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2007-06 | PHASE4 |
| NCT02799498 | Amgen | Healthy Men and Women | 2003-10 | PHASE1 |
| NCT01793285 | Pfizer | Ankylosing Spondylitis | 2010-12 | |
| NCT00443950 | Wyeth is now a wholly owned subsidiary of Pfizer | Arthritis, Rheumatoid | 2006-06 | PHASE3 |
| NCT04507776 | Pfizer | Spondyloarthrosis | 2020-09-01 | |
| NCT00111956 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Massachusetts General Hospital | Metabolic Syndrome X | 2004-04 | PHASE2|PHASE3 |
| NCT02308163 | Astellas Pharma Inc | Rheumatoid Arthritis | 2014-08-08 | PHASE3 |
| NCT00484237 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2007-04 | PHASE3 |
| NCT00094341 | Amgen | Rheumatoid Arthritis | 2004-10 | PHASE4 |
| NCT00001954 | National Institute of Dental and Craniofacial Research (NIDCR) | Sjogren´s Syndrome | 1999-12 | PHASE2 |
| NCT00581100 | Wyeth is now a wholly owned subsidiary of Pfizer | Nail Psoriasis|Plaque Psoriasis | 2007-09 | PHASE4 |
| NCT00888628 | Massachusetts General Hospital|Boston Area Diabetes Endocrinology Research Center (funded by NIDDK) | Diabetes Mellitus, Type I | 2009-05 | PHASE1|PHASE2 |
| NCT00444340 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2004-04 | PHASE4 |
| NCT03880968 | Second Affiliated Hospital, School of Medicine, Zhejiang University|Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine|First Affiliated Hospital of Wenzhou Medical University|Affiliated Hospital of Jiaxing University|Shaoxing Second Hospital|Shanghai Jiao Tong University Affiliated Sixth People´s Hospital|Ningbo Medical Center Lihuili Hospital|Wenzhou Central Hospital|Zhejiang Provincial People´s Hospital|Shaoxing People´s Hospital | Spondylitis, Ankylosing | 2012-03-01 | |
| NCT00962741 | Pfizer | Arthritis, Juvenile Idiopathic | 2009-09 | PHASE3 |
| NCT00135720 | Massachusetts General Hospital|Brigham and Women´s Hospital|Stanford University | Pemphigus Vulgaris | 2004-06 | PHASE2 |
| NCT01891864 | Sandoz|Hexal AG | Chronic Stable Plaque Psoriasis | 2013-06 | PHASE3 |
| NCT01875991 | Amgen | Rheumatoid Arthritis|Plaque Psoriasis | 2013-06-05 | PHASE4 |
| NCT01623752 | Pfizer | Rheumatoid Arthritis|Psoriasis Arthritis | 2012-02 | |
| NCT00730392 | State University of New York at Buffalo|Amgen | Type 1 Diabetes | 2002-10 | PHASE1|PHASE2 |
| NCT01706692 | Swiss Dermatology Network for Targeted Therapies | Psoriasis | 2011-02 | |
| NCT00201812 | Ohio State University Comprehensive Cancer Center|Immunex Corporation | Tumors | 2000-11 | PHASE1 |
| NCT03792841 | Amgen | Metastatic Castration-resistant Prostate Cancer|Prostate Cancer | 2019-02-05 | PHASE1 |
| NCT03780959 | Amgen | Juvenile Rheumatoid Arthritis | 1997-05-01 | PHASE2|PHASE3 |
| NCT00276029 | University Hospitals, Leicester | Asthma | 2003-12 | NA |
| NCT00421980 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2002-06 | PHASE3 |
| NCT00410046 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2006-12 | PHASE4 |
| NCT00858780 | Pfizer | Rheumatoid Arthritis | 2009-01 | PHASE4 |
| NCT00503139 | Pfizer | Rheumatoid Arthritis | 2007-07 | |
| NCT02987257 | Vanderbilt University Medical Center|University of Ottawa|University of Toronto | Stevens-Johnson Syndrome|Toxic Epidermal Necrolyses | 2023-03-21 | PHASE3 |
| NCT01729754 | Sun Pharmaceutical Industries Limited | Plaque Psoriasis | 2013-02-05 | PHASE3 |
| NCT00783536 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2008-11 | PHASE4 |
| NCT00413400 | Massachusetts General Hospital|Amgen | Metabolic Syndrome | 2006-12 | NA |
| NCT02031211 | Stanford University | CRPS|Chronic Regional Pain Syndrome | 2014-06 | NA |
| NCT01793519 | Georgetown University|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|University of Maryland, Baltimore|Washington D.C. Veterans Affairs Medical Center|Medstar Health Research Institute|Patient-Centered Outcomes Research Institute|Arthritis and Pain Associates of PG County|Arthritis & Rheumatism Associates, P.C.|Rheumatology Associates of Baltimore, L.L.C.|The Arthritis Clinic of Northern Virginia, P.C.|Arthritis and Rheumatic Disease Associates, P.C. | Rheumatoid Arthritis | 2013-01 | PHASE4 |
| NCT06585384 | Fondation Ophtalmologique Adolphe de Rothschild | Alzheimer Disease | 2025-03 | PHASE1 |
| NCT06016517 | Tufts Medical Center | Arthritis, Rheumatoid | 2026-05-01 | |
| NCT01258738 | Pfizer | Spondylitis, Ankylosing | 2011-02 | PHASE3 |
| NCT00364572 | Johns Hopkins University|Walter Reed Army Medical Center | Sciatica | 2006-05 | PHASE1|PHASE2 |
| NCT00115219 | Amgen | Rheumatoid Arthritis | 2005-05 | PHASE4 |
| NCT05424393 | The First Affiliated Hospital of Xiamen University | Rheumatoid Arthritis | 2022-03-04 | |
| NCT00006070 | National Institute of Dental and Craniofacial Research (NIDCR) | Healthy|Inflammation | 2000-07 | PHASE2 |
| NCT01812954 | Jochen Schmitt.|Merck Sharp & Dohme LLC | Psoriasis | 2013-03 | |
| NCT05135312 | OptiSkin Medical|Amgen | Psoriasis|Psoriatic Arthritis|Psoriatic Nail | 2021-08-09 | PHASE4 |
| NCT00285779 | Stanford University|Wright State University|Tufts Medical Center|University of Louisville|Wake Forest University Health Sciences|University of Michigan|Emory University|University Hospitals Cleveland Medical Center|Icahn School of Medicine at Mount Sinai|Oregon Health and Science University|The Cleveland Clinic|Fivenson, David, M.D. | Lichen Planus | 2006-08 | PHASE2 |
| NCT00520572 | AstraZeneca | Rheumatoid Arthritis | 2007-08 | PHASE2 |
| NCT00768053 | Wyeth is now a wholly owned subsidiary of Pfizer|Lincoln Medical and Mental Health Center|Umanis|SODIA|depolabo | Rheumatoid Arthritis | 2008-10 | PHASE4 |
| NCT03160001 | Faiq Gorial | Rheumatoid Arthritis (RA) | 2017-08-15 | PHASE1|PHASE2 |
| NCT00111111 | Amgen | Psoriasis | | PHASE3 |
| NCT04485325 | Dr. Frank Behrens|Pfizer | Rheumatic Arthritis | 2019-11-04 | PHASE4 |
| NCT00134394 | University of Medicine and Dentistry of New Jersey | Psoriasis | 2005-02 | PHASE2 |
| NCT02202850 | Pfizer | Ankylosing Spondylitis | 2014-08-12 | |
| NCT02986139 | Amgen | Arthritis, Rheumatoid; Arthritis, Psoriatic | 2016-11-29 | PHASE3 |
| NCT00005853 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes | 1999-12 | PHASE2 |
| NCT02486302 | Pfizer | Rheumatoid Arthritis|Psoriatic Arthritis|Axial Spondyloarthritis|Plaque Psoriasis | 2015-03-24 | |
| NCT03294954 | Baylor College of Medicine|Center for Cell and Gene Therapy, Baylor College of Medicine | Neuroblastoma | 2018-01-18 | PHASE1 |
| NCT00063869 | Wyeth is now a wholly owned subsidiary of Pfizer | Pulmonary Fibrosis | | PHASE2 |
| NCT00713544 | AstraZeneca | Rheumatoid Arthritis | 2008-07 | PHASE2 |
| NCT01001208 | Amgen|Immunex Corporation | Psoriasis | 2009-11 | PHASE3 |
| NCT00434811 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | 2006-10 | PHASE3 |
| NCT03016260 | TcLand Expression S.A.|European Commission | RheumatoId Arthritis | 2016-12 | |
| NCT02656082 | University of Leeds|National Institute for Health Research, United Kingdom|Pfizer|Clinical Trials Research Unit, Leeds | Lupus Erythematosus, Discoid|Lupus Erythematosus, Cutaneous|Lupus Erythematosus, Chronic Cutaneous | 2016-02-01 | PHASE2 |
| NCT02464878 | Massachusetts General Hospital|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Iowa | Kidney Transplant|Type 1 Diabetes | 2017-01 | PHASE2 |
| NCT00691964 | AbbVie (prior sponsor, Abbott)|Paragon Biomedical | Plaque Psoriasis | 2008-05 | PHASE3 |
| NCT00110981 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis | 2005-03 | PHASE4 |
| NCT00434044 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2007-02 | PHASE3 |
| NCT02433184 | University of Leeds | Rheumatoid Arthritis | 2011-07 | PHASE4 |
| NCT00482170 | Pfizer | Psoriasis | 2007-09 | PHASE3 |
| NCT02202837 | Pfizer | Rheumatoid Arthritis | 2014-08-12 | |
| NCT00141921 | Amgen | Pediatric Plaque Psoriasis | 2005-08-11 | PHASE3 |
| NCT02999776 | Pantec Biosolutions AG | Psoriatic Plaque | 2016-11 | PHASE1 |
| NCT00195338 | Pfizer|Innovex, Inc | Rheumatoid Arthritis | 2004-05 | |
| NCT00726375 | University of Michigan Rogel Cancer Center | Acute Graft Versus Host Disease | 2008-05 | PHASE3 |
| NCT00524381 | Bispebjerg Hospital | Polymyalgia Rheumatica | 2007-08 | PHASE3 |
| NCT00447265 | National Institute of Allergy and Infectious Diseases (NIAID) | Lupus Nephritis | 2008-02 | PHASE2 |
| NCT02274792 | Amgen | Plaque Psoriasis | 2015-01 | PHASE4 |
| NCT00791765 | Amgen | Psoriasis | 2008-10 | PHASE4 |
| NCT02374021 | Brigham and Women´s Hospital|Columbia University | Arthritis, Rheumatoid | 2016-07 | PHASE4 |
| NCT01145352 | Pfizer | Juvenile Idiopathic Arthritis | 2009-07 | |
| NCT00195364 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis|Inflammation | 2003-07 | |
| NCT00523692 | University Hospital Birmingham|Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2007-09 | PHASE4 |
| NCT00833729 | Dermatrials Research|Amgen | Plaque Psoriasis | 2009-02 | PHASE4 |
| NCT00133315 | Hvidovre University Hospital | Spondylarthropathies|Ankylosing Spondylitis|Psoriatic Arthritis | 2004-09 | PHASE4 |
| NCT01289730 | Charite University, Berlin, Germany|Rheumazentrum Ruhrgebiet | Spondyloarthritis | 2002-02 | PHASE2 |
| NCT00333034 | Wyeth is now a wholly owned subsidiary of Pfizer|Amgen | Psoriasis | 2006-06 | PHASE3 |
| NCT00317538 | Centocor Ortho Biotech Services, L.L.C. | Rheumatoid Arthritis | 2003-06 | PHASE3 |
| NCT04973566 | Janssen Research & Development, LLC | Healthy | 2021-08-31 | PHASE1 |
| NCT01557322 | Pfizer | Rheumatoid Arthritis | 2011-10 | |
| NCT00454584 | Centocor, Inc. | Psoriasis | 2007-03 | PHASE3 |
| NCT00141791 | Wyeth is now a wholly owned subsidiary of Pfizer | Asthma | 2005-05 | PHASE2 |
| NCT03728478 | Istituto Giannina Gaslini|Agenzia Italiana del Farmaco|Compagnia di San Paolo|Pfizer | Oligoarthritis, Juvenile|Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2019-05-29 | PHASE3 |
| NCT00844142 | Charite University, Berlin, Germany|Wyeth is now a wholly owned subsidiary of Pfizer | Moderate to Severe Active Axial Spondyloarthritis | 2005-11 | PHASE2 |
| NCT00409318 | Massachusetts General Hospital|Amgen | Metabolic Syndrome | 2004-04 | NA |
| NCT01578850 | Pfizer | Rheumatoid Arthritis | 2012-07 | PHASE4 |
| NCT03100253 | Mario Negri Institute for Pharmacological Research | Rheumatoid Arthritis | 2018-03-01 | PHASE4 |
| NCT02722772 | First Affiliated Hospital of Harbin Medical University|Shanghai baiying pharmaceutical technology Co., Ltd. | Osteoarthritis of Knee | 2016-02 | NA |
| NCT00116181 | Rockefeller University|Amgen | Psoriasis | 2004-10 | PHASE3 |
| NCT01927757 | Amgen | Moderate to Severe Rheumatoid Arthritis | 2013-05-06 | PHASE4 |
| NCT00091741 | Georgetown University|Advanced Biotherapy, Inc. | HIV Infection | | PHASE1 |
| NCT00116272 | Amgen | Pregnancy | 2005-04 | |
| NCT02878161 | Fen Li | Rheumatoid Arthritis | 2016-01 | PHASE4 |
| NCT00705042 | Wyeth is now a wholly owned subsidiary of Pfizer | Healthy Subjects | 2008-07 | PHASE1 |
| NCT00346294 | Amgen|Immunex Corporation | Rheumatoid Arthritis | 2006-01 | PHASE4 |
| NCT00195403 | Pfizer | Rheumatoid Arthritis | 2004-05 | |
| NCT00502879 | Wyeth is now a wholly owned subsidiary of Pfizer | Healthy | 2007-07 | PHASE1 |
| NCT01233583 | University of Aberdeen|NHS Grampian | Psoriasis | 2010-06 | |
| NCT00249041 | Amgen|Immunex Corporation | Rheumatoid Arthritis | 2005-10 | PHASE3 |
| NCT00789308 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Clinical Islet Transplantation Consortium | Diabetes Mellitus, Type I | 2008-07-11 | PHASE2 |
| NCT01170715 | Rockefeller University|Weill Medical College of Cornell University | Psoriasis | 2010-07-13 | NA |
| NCT04582084 | AryoGen Pharmed Co. | Rheumatoid Arthritis|Ankylosing Spondylitis|Psoriatic Arthritis | 2014-04-04 | |
| NCT03178955 | University of California, Davis | Rheumatoid Arthritis | 2017-03-27 | |
| NCT03182426 | University of Alberta|Alberta Innovates Health Solutions | Diabetes Mellitus, Type 1 | 2017-08-15 | PHASE1|PHASE2 |
| NCT00107991 | University of Pennsylvania | Hidradenitis Suppurativa | 2005-04 | PHASE2 |
| NCT02109289 | Innovaderm Research Inc. | Rheumatoid Arthritis|Vascular Inflammation | 2014-04 | PHASE4 |
| NCT04066348 | Wayne State University|University of Miami|Michigan Ear Institute | Tinnitus, Noise Induced | 2022-07-01 | PHASE2 |
| NCT00111436 | Amgen|Immunex Corporation|Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis | 2003-04 | PHASE3 |
| NCT00078819 | Amgen | Psoriasis | 2004-09-08 | PHASE3 |
| NCT02144857 | University of Athens | Psoriasis | 2014-05-30 | PHASE4 |
| NCT01597245 | Eli Lilly and Company | Psoriasis | 2012-05-18 | PHASE3 |
| NCT01894412 | Hanwha Chemical | Healthy | 2013-07 | PHASE1 |
| NCT00565409 | Pfizer | Arthritis, Rheumatoid | 2008-03 | PHASE4 |
| NCT00848354 | Pfizer|Amgen | Rheumatoid Arthritis | 2009-06 | PHASE4 |
| NCT00293202 | Kaysen, George A., M.D., Ph.D.|Amgen|Dialysis Clinic, Inc. | End Stage Renal Disease | 2005-01 | PHASE2 |
| NCT01030120 | University of Utah | Chronic Idiopathic Urticaria | 2010-12 | PHASE2|PHASE3 |
| NCT07352566 | University of California, San Francisco | Psoriasis|Atopic Dermatitis | 2026-01-01 | PHASE4 |
| NCT00967538 | Innovaderm Research Inc.|Amgen | Psoriasis | 2009-09 | PHASE4 |
| NCT01989689 | Emory University|Amgen | PSORIASIS | 2010-08 | PHASE2 |
| NCT02766439 | Yang Beibei | Rhupus Syndrome, Etanercept | 2013-03 | |
| NCT00663052 | Pfizer | Plaque Psoriasis|Psoriasis | 2008-06 | PHASE4 |
| NCT00413452 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2006-12 | PHASE3 |
| NCT00121615 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Inflammation|Psoriasis | 2004-10 | PHASE3 |
| NCT04345458 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Ankylosing Spondylitis | 2014-03-06 | PHASE3 |
| NCT00195416 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2005-06 | |
| NCT02132234 | Jagiellonian University|Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland | Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Hypertension | 2013-06 | PHASE4 |
| NCT00484809 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2004-03 | |
| NCT00361634 | Amgen | Rheumatoid Arthritis | 2006-09 | PHASE1 |
| NCT00434850 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes Mellitus, Type 1 | 2006-10 | PHASE2 |
| NCT00418548 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2004-06 | PHASE3 |
| NCT02376790 | Amgen | Psoriatic Arthritis | 2015-03-03 | PHASE3 |
| NCT03403140 | Gema Biotech S.A.|QUID Quality in Drugs and Devices Latin American Consulting SRL | Rheumatoid Arthritis | 2016-10-06 | PHASE3 |
| NCT01298531 | Pfizer | Axial Spondyloarthritis | 2011-05 | PHASE4 |
| NCT00432406 | Chinese University of Hong Kong | Psoriatic Arthritis | 2006-05 | PHASE4 |
| NCT02960035 | Sun Yat-sen University | Spondyloarthropathy | 2014-04 | PHASE4 |
| NCT00078806 | Amgen|Immunex Corporation | Juvenile Rheumatoid Arthritis | 2001-06-04 | PHASE3 |
| NCT01313221 | Amgen | Psoriasis | 2011-04 | PHASE3 |
| NCT02588534 | Amgen | Healthy Men and Women | 2004-08 | PHASE1 |
| NCT00317499 | Amgen|Immunex Corporation | Psoriatic Arthritis|Psoriasis | 2000-04 | PHASE3 |
| NCT00293709 | Pfizer | Arthritis, Psoriatic|Psoriasis|Skin Diseases, Papulosquamous | 2006-01 | |
| NCT03781375 | Amgen | Juvenile Rheumatoid Arthritis | 2000-08-24 | PHASE3 |
| NCT01716637 | Life Extension Foundation Inc. | Alzheimer´s Disease | 2010-02 | PHASE1 |
| NCT03273088 | AryoGen Pharmed Co. | Phase 1|Bioequivalence | 2016-12-04 | PHASE1 |
| NCT00357903 | Amgen|Immunex Corporation | Rheumatoid Arthritis | 1997-04 | PHASE3 |
| NCT01865630 | Unity Health Toronto | Subarachnoid Hemorrhage, Aneurysmal | 2021-01 | PHASE1 |
| NCT00913458 | Pfizer | Active Rheumatoid Arthritis|Arthritis, Rheumatoid|Rheumatoid Arthritis | 2009-09 | PHASE4 |
| NCT00420238 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2007-01 | PHASE4 |
| NCT02489760 | Chung Shan Medical University | Ankylosing Spondylitis | 2008-07 | PHASE4 |
| NCT06596772 | mAbxience Research S.L. | Rheumatoid Arthritis (RA) | 2024-10-03 | PHASE3 |
| NCT00195494 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2004-11 | PHASE4 |
| NCT00031551 | National Institute of Nursing Research (NINR) | Stomatitis | 2002-03 | PHASE2 |
| NCT00205231 | University of Wisconsin, Madison|Immunex Corporation | HIV Infections | 2002-05 | NA |
| NCT00141739 | University of Michigan Rogel Cancer Center | Graft-Versus-Host Disease | 2004-08 | PHASE2 |
| NCT01230177 | Pfizer | Arthritis|Rheumatoid | 2011-05 | |
| NCT04255498 | South Florida Veterans Affairs Foundation for Research and Education|Nova Southeastern University|United States Department of Defense | Gulf War Illness|Persian Gulf Syndrome|Occupational Diseases | 2017-10-30 | PHASE1 |
| NCT02915354 | Sun Yat-sen University | Spondylitis, Ankylosing|Recurrence | 2007-07 | PHASE4 |
| NCT00217386 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2004-03 | PHASE2 |
| NCT03193203 | Samsung Bioepis Co., Ltd. | Healthy | 2017-03-24 | PHASE1 |
| NCT00910273 | Pfizer|Lincoln Medical and Mental Health Center | Ankylosing Spondylitis | 2009-07 | PHASE4 |
| NCT00001955 | National Institute of Dental and Craniofacial Research (NIDCR) | Temporomandibular Joint Disorder | 1999-12 | PHASE2 |
| NCT02134210 | Coherus Oncology, Inc.|Shire | Plaque Psoriasis | 2014-06-16 | PHASE3 |
| NCT06707194 | Nanfang Hospital, Southern Medical University | Spondyloarthritis (SpA)|Ankylosing Spondylitis (AS) | 2025-06-14 | PHASE4 |
| NCT00710580 | AbbVie (prior sponsor, Abbott)|Paragon Biomedical | Moderate to Severe Plaque Psoriasis | 2008-07 | PHASE3 |
| NCT02330380 | University Hospitals Cleveland Medical Center|National Psoriasis Foundation | Psoriasis|Inflammation | 2013-04 | |
| NCT00789997 | Ottawa Hospital Research Institute | COPD Exacerbation | 2008-11 | PHASE2|PHASE3 |
| NCT02346240 | UCB Biopharma S.P.R.L. | Psoriasis|Plaque Psoriasis | 2015-02-11 | PHASE3 |
| NCT01646385 | Pfizer | Rheumatoid Arthritis | 2012-02 | |
| NCT00841789 | Michael Portman|Amgen | Mucocutaneous Lymph Node Syndrome|Kawasaki Disease | 2009-03 | PHASE2 |
| NCT01558089 | Pfizer | Rheumatoid Arthritis | 2013-03 | |
| NCT00421915 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2002-03 | PHASE3 |
| NCT01646177 | Eli Lilly and Company | Psoriasis | 2012-07-28 | PHASE3 |
| NCT00445770 | Pfizer | Arthritis, Rheumatoid | 2006-07 | PHASE3 |
| NCT01132235 | Florida Academic Dermatology Centers|Amgen | Psoriasis | 2010-04 | PHASE4 |
| NCT00421174 | National Heart, Lung, and Blood Institute (NHLBI)|Blood and Marrow Transplant Clinical Trials Network|National Cancer Institute (NCI)|National Marrow Donor Program | Pneumonia|Idiopathic Pneumonia Syndrome | 2007-08 | PHASE3 |
| NCT00112385 | Brigham and Women´s Hospital|Amgen | Dermatomyositis | 2006-03 | PHASE1 |
| NCT00332332 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis | 2006-03 | PHASE4 |
| NCT00873730 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2006-12 | PHASE4 |
| NCT07138898 | NYU Langone Health | Rheumatic Disease | 2025-09 | PHASE2 |
| NCT07386587 | University of Child Health Sciences and Children´s Hospital, Lahore | Juvenile Idiopathic Arthritis | 2026-01-27 | PHASE3 |
| NCT00405275 | US Department of Veterans Affairs|Canadian Institutes of Health Research (CIHR)|Rheumatoid Arthritis Investigational Network (RAIN)|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Rheumatoid Arthritis | 2007-07 | NA |
| NCT03414502 | University of Nebraska | Rheumatoid Arthritis | 2007-12-10 | PHASE3 |
| NCT01731457 | Medical University of Warsaw | Transplanted Kidney Ischemia Reperfusion Injury | 2011-04 | PHASE2 |
| NCT02313922 | Zhejiang University|Shanghai CP Guojian Pharmaceutical Co., Ltd. | Psoriasis | 2014-11 | PHASE4 |
| NCT00420303 | Wyeth is now a wholly owned subsidiary of Pfizer | Spondylarthropathies, Enthesitis | 2007-01 | PHASE4 |
| NCT04585711 | Duke University|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Juvenile Idiopathic Arthritis|Rheumatoid Arthritis|Obesity | 2026-07-01 | PHASE1 |
| NCT04725422 | Seattle Children´s Hospital|Boston Children´s Hospital, Boston, MA, USA|Hospital for Special Surgery, New York|Joseph M Sanzari Children´s Hospital, Hackensack University Medical Center, Hackensack, NJ, USA|Riley Children´s Hospital, Indianapolis, IN, USA|University of North Carolina, Chapel Hill, NC, USA|Royal Children´s Hospital|Hacettepe University|Bambino Gesù Children´s Hospital, Rome, Italy|University of British Columbia, Vancouver, BC, Canada|Meyer Children´s Hospital, Florence, Italy|Mansoura University|University of Utah, Salt Lake City, UT, USA|University of Iowa Carver College of Medicine, Iowa City, IA, USA|Ann & Robert H Lurie Children´s Hospital of Chicago|Palacky University Olomouc Institute of Molecular and Translational Medicine, Olomouc, Czechia|Alder Hey Children´s NHS Foundation Trust|University of Calgary | Chronic Nonbacterial Osteomyelitis|Chronic Recurrent Multifocal Osteomyelitis | 2018-08-01 | |
| NCT00733096 | Johns Hopkins University|Walter Reed Army Medical Center|National Naval Medical Center|Womack Army Medical Center|Landstuhl Regional Medical Center|Massachusetts General Hospital | Lumbosacral Radiculopathy | 2008-08 | PHASE2|PHASE3 |
| NCT00134368 | University of Medicine and Dentistry of New Jersey | Vitiligo | 2003-11 | PHASE2 |
| NCT05950724 | Northwestern University | Lung Transplant; Complications | 2023-09-17 | EARLY_PHASE1 |
| NCT03955861 | Belfast Health and Social Care Trust|British Medical Association|Psoriasis and Psoriatic Arthritis Alliance|Queen´s University, Belfast | Psoriatic Arthritis|Psoriasis|Enthesitis | 2019-02-14 | |
| NCT01901185 | Amgen | Rheumatoid Arthritis|Psoriatic Arthritis | 2013-06-11 | PHASE3 |
| NCT01783015 | Pfizer | Rheumatoid Arthritis | 2013-09 | PHASE4 |
| NCT00546533 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2003-01 | PHASE4 |
| NCT00443430 | Seattle Children´s Hospital|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Amgen | Juvenile Chronic Polyarthritis|Juvenile Idiopathic Arthritis|Juvenile Rheumatoid Arthritis | 2007-05 | PHASE4 |
| NCT00509600 | M.D. Anderson Cancer Center|Amgen | Leukemia | 2004-09 | PHASE2 |
| NCT01895309 | Samsung Bioepis Co., Ltd. | Rheumatoid Arthritis | 2013-06 | PHASE3 |
| NCT02164214 | Assistance Publique Hopitaux De Marseille | Inflammatory Rheumatism|Psoriatic Arthritis|Rheumatoid Arthritis | 2011-09 | PHASE3 |
| NCT00581555 | Pfizer | Psoriasis | 2007-10 | PHASE4 |
| NCT00837434 | National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Rho Federal Systems Division, Inc. | Rheumatoid Arthritis | 2009-03 | PHASE4 |
| NCT00356356 | Amgen|Immunex Corporation | Ankylosing Spondylitis | 2002-04 | PHASE3 |
| NCT04077957 | Nanfang Hospital, Southern Medical University | Ankylosing Spondylitis|Spondyloarthritis | 2019-10-07 | PHASE4 |
| NCT02722811 | First Affiliated Hospital of Harbin Medical University|Shanghai Baiying Medical Technology Co., Ltd. | Osteoarthritis Of Knee | 2016-02 | NA |
| NCT00825344 | Johns Hopkins University|Walter Reed Army Medical Center|John P. Murtha Neuroscience and Pain Institute | Inguinal Hernia|Postoperative Pain | 2009-01 | NA |
| NCT00141713 | University of Michigan Rogel Cancer Center | Graft-Versus-Host Disease | 2003-10 | PHASE2 |
| NCT00640393 | Innovaderm Research Inc.|Amgen | Psoriasis Vulgaris | 2008-04 | PHASE4 |
| NCT00468117 | National Institute of Allergy and Infectious Diseases (NIAID)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Type 1 Diabetes Mellitus | 2007-01 | PHASE3 |
| NCT00708708 | Pfizer | Psoriasis | 2008-06 | |
| NCT02364479 | Sun Yat-sen University | Spondyloarthritis | 2014-02-10 | PHASE4 |
| NCT00356590 | Amgen|Immunex Corporation | Rheumatoid Arthritis | 1998-12 | PHASE3 |
| NCT01657513 | University Hospital, Gentofte, Copenhagen|The Michaelsen Foundation|Pfizer | Psoriasis | 2012-06 | NA |
| NCT00245960 | Wyeth is now a wholly owned subsidiary of Pfizer | Psoriatic Arthritis | 2005-12-27 | PHASE4 |
| NCT00949546 | Penn State University|Amgen | Hidradenitis Suppurativa | 2005-04 | |
| NCT03649061 | P. Verschueren|Belgium Health Care Knowledge Centre | Arthritis, Rheumatoid | 2018-06-08 | PHASE4 |
| NCT00201682 | John Byrd | Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma | 2002-10 | PHASE1|PHASE2 |
| NCT04449224 | Hanyang University|Ministry of Health, Republic of Korea | Rheumatoid Arthritis | 2020-04-27 | |
| NCT04079374 | Joint Stock Company "Farmak"|Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Rheumatoid Arthritis | 2018-09-03 | PHASE3 |
| NCT01313208 | Amgen | Rheumatoid Arthritis | 2011-03 | PHASE4 |
| NCT00046904 | Mayo Clinic|National Cancer Institute (NCI) | Anorexia|Cachexia|Unspecified Adult Solid Tumor, Protocol Specific | 2003-05 | PHASE3 |
| NCT04082910 | Chinese PLA General Hospital | Solid Tumor|Hematological Malignancy | 2019-09-15 | PHASE1|PHASE2 |
| NCT00802815 | Washington University School of Medicine|Amgen | Inclusion Body Myositis | 2005-04 | EARLY_PHASE1 |
| NCT01270997 | Hanwha Chemical | Rheumatoid Arthritis | 2010-12 | PHASE3 |
| NCT02464033 | Johnny Ludvigsson|Swedish Child Diabetes Foundation|Ostergotland County Council, Sweden|Diamyd Medical AB | Diabetes Mellitus, Type 1 | 2015-05 | PHASE2 |
| NCT02471144 | Novartis Pharmaceuticals | Chronic Severe Plaque-type Psoriasis | 2015-09-29 | PHASE3 |
| NCT05164198 | Hanyang University Seoul Hospital|Linical Korea | Ankylosing Spondylitis|Axial Spondyloarthritis | 2022-01-15 | PHASE4 |
| NCT00683384 | Wyeth is now a wholly owned subsidiary of Pfizer | Arthritis, Psoriatic | 2007-01 | |
| NCT00259610 | University of Alabama at Birmingham|Amgen|Barr Laboratories|Pfizer | Rheumatoid Arthritis | 2004-05 | PHASE4 |
| NCT01764997 | Sanofi|Regeneron Pharmaceuticals | Rheumatoid Arthritis | 2013-04 | PHASE3 |
| NCT01971346 | University of Michigan|Amgen | Psoriasis | 2014-03-13 | PHASE4 |
| NCT03976245 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph´s|Academic Medical Organization of Southwestern Ontario | Rheumatoid Arthritis | 2020-03-01 | PHASE4 |
| NCT00203359 | Tobinick, Edward Lewis, M.D. | Alzheimer´s Disease | 2004-09 | PHASE1 |
| NCT00678782 | University of Padova|Wyeth is now a wholly owned subsidiary of Pfizer|Azienda Ospedaliera di Padova | Persistent Knee Joint Synovitis | 2005-04 | PHASE2 |
| NCT00832364 | Stiefel, a GSK Company|GlaxoSmithKline | Plaque Psoriasis | 2009-10 | PHASE4 |
| NCT02809781 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University|Nanfang Hospital, Southern Medical University|Second Affiliated Hospital of Guangzhou Medical University | Spondylitis|Spondylitis, Ankylosing|Ankylosis|Arthritis|Spondylarthritis|Spondylarthropathies|Spinal Diseases|Musculoskeletal Diseases|Bone Diseases | 2016-06 | PHASE2|PHASE3 |
| NCT00931957 | Tehran University of Medical Sciences|Wyeth is now a wholly owned subsidiary of Pfizer | Behcet Syndrome|Uveal Disease | 2010-10 | NA |
| NCT03636373 | Rutgers, The State University of New Jersey|Amgen | Gout Attack | 2019-10-25 | PHASE4 |
| NCT01237262 | University of Padova | Moderate to Severe Psoriasis.|Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern. | 2010-11 | PHASE4 |
| NCT00195377 | Wyeth is now a wholly owned subsidiary of Pfizer | Arthritis, Psoriatic|Arthritis, Rheumatoid | 2003-04 | |
| NCT03073200 | Eli Lilly and Company | Plaque Psoriasis | 2017-03-28 | PHASE3 |
| NCT00141726 | University of Michigan Rogel Cancer Center | Lung Injury, Acute|Respiratory Distress Syndrome, Adult|Bronchiolitis Obliterans | 2003-10 | PHASE2 |
| NCT01100034 | Pfizer | Psoriasis | 2010-11-19 | |
| NCT00477191 | Massachusetts General Hospital|Amgen | Psoriasis|Metabolic Syndrome|Hyperlipidemia|Obesity|Hypertension | 2007-05 | NA |
| NCT01394913 | EMS | Rheumatoid Arthritis | 2013-08 | PHASE3 |
| NCT02373813 | Amgen | Rheumatoid Arthritis | 2015-02-20 | PHASE3 |
| NCT00048373 | Baylor College of Medicine|The Methodist Hospital Research Institute | Histiocytosis, Langerhans-Cell | 2001-10 | PHASE2 |
| NCT00796705 | National Institute of Allergy and Infectious Diseases (NIAID) | Rheumatoid Arthritis | 2008-11 | PHASE4 |
| NCT01000441 | University Hospital, Strasbourg, France | Rheumatoid Arthritis | 2009-12-23 | PHASE4 |
| NCT00965666 | Children´s Hospital Medical Center, Cincinnati|Amgen | Fanconi Anemia | 2005-10 | EARLY_PHASE1 |
| NCT00322439 | Amgen | Psoriasis | 2006-05-01 | |
| NCT00005007 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|FDA Office of Orphan Products Development | Wegener´s Granulomatosis | 2000-06 | PHASE2|PHASE3 |
| NCT04267614 | Pfizer | Arthritis Rheumatoid | 2018-11-01 | |
| NCT01287715 | Erasmus Medical Center|Dutch Arthritis Association | Juvenile Idiopathic Arthritis | 2011-01 | PHASE4 |
| NCT00001901 | National Institute of Allergy and Infectious Diseases (NIAID) | Vasculitis|Wegener´s Granulomatosis | 1999-02 | PHASE2 |
| NCT00724672 | Merck Sharp & Dohme LLC | Rheumatoid Arthritis | 2008-09 | |
| NCT00309907 | Children´s Oncology Group|National Cancer Institute (NCI) | Accelerated Phase Chronic Myelogenous Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Chronic Phase Chronic Myelogenous Leukemia|de Novo Myelodysplastic Syndromes|Disseminated Neuroblastoma|Juvenile Myelomonocytic Leukemia|Previously Treated Childhood Rhabdomyosarcoma|Previously Treated Myelodysplastic Syndromes|Pulmonary Complications|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Neuroblastoma|Recurrent Wilms Tumor and Other Childhood Kidney Tumors|Recurrent+Refractory Childhood Hodgkin Lymphoma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes | 2006-04 | PHASE2 |
| NCT00195507 | Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis | 2004-12 | PHASE4 |
| NCT00581165 | Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis | 2006-02 | PHASE4 |
| NCT05281614 | Benaroya Research Institute|University of California, San Diego | Type 1 Diabetes | 2022-09-21 | EARLY_PHASE1 |
| NCT01358578 | Novartis Pharmaceuticals | Chronic Plaque Psoriasis | 2011-06 | PHASE3 |
| NCT04610476 | University of Erlangen-Nürnberg Medical School | Psoriatic Arthritis|Withdrawal|Reduction | 2020-10-19 | PHASE3 |
| NCT03033095 | University Hospital, Grenoble | Spondylitis, Ankylosing | 2016-07 | NA |
| NCT02092467 | Pfizer | Arthritis, Rheumatoid | 2014-03-14 | PHASE4 |
| NCT01276847 | Merck Sharp & Dohme LLC | Psoriasis | 2011-03 | PHASE1 |
| NCT00654368 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2008-06 | PHASE4 |
| NCT00161655 | Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis|Arthritis, Psoriatic | 2005-04 | PHASE4 |
| NCT00247962 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2005-12 | PHASE4 |
| NCT00029328 | FDA Office of Orphan Products Development | Respiratory Distress Syndrome, Adult|Bronchiolitis Obliterans|Pneumonia | 2001-09 | PHASE1|PHASE2 |
| NCT02378506 | Pfizer | Arthritis, Rheumatoid | 2015-04 | PHASE3 |
| NCT00522184 | Centre Hospitalier Universitaire de Nice|Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2005-02 | PHASE3 |
| NCT00252668 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2004-06 | PHASE4 |
| NCT02749370 | Amgen | Plaque Psoriasis | 2016-05-18 | PHASE4 |
| NCT00784966 | Virginia Commonwealth University|University of Miami | Type 1 Diabetes Mellitus | 2011-08 | PHASE1|PHASE2 |
| NCT00203320 | Tobinick, Edward Lewis, M.D. | Alzheimer´s Disease | 2005-04 | PHASE1 |
| NCT00706797 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2008-09 | PHASE4 |
| NCT00329823 | University of Athens | Hidradenitis Suppurativa | 2005-09 | PHASE2 |
| NCT00729131 | National Institute of Environmental Health Sciences (NIEHS) | Bronchitis | 2008-08 | |
| NCT00293722 | Pfizer | Arthritis, Psoriatic|Psoriasis|Skin Diseases, Papulosquamous | 2006-01 | |
| NCT00458185 | Wyeth is now a wholly owned subsidiary of Pfizer | Ankylosing Spondylitis | 2006-08 | PHASE4 |
| NCT02821026 | University of Alberta | Type 1 Diabetes | 2016-05 | PHASE1|PHASE2 |
| NCT00800982 | University of California, San Francisco | Psoriasis | 2008-10 | NA |
| NCT02258282 | Chengdu PLA General Hospital | Psoriasis | 2014-05 | NA |
| NCT02509026 | Pfizer | Spondylitis, Ankylosing | 2015-09-24 | PHASE4 |
| NCT01936688 | Sun Pharmaceutical Industries Limited | Plaque-type Psoriasis | 2013-09 | PHASE3 |
| NCT00111449 | Amgen|Wyeth is now a wholly owned subsidiary of Pfizer | Psoriasis | 2003-06 | PHASE3 |
| NCT01730495 | Haukeland University Hospital | Chronic Fatigue Syndrome|Myalgic Encephalomyelitis | 2012-10 | PHASE2 |
| NCT01021735 | University of Glasgow|Arthritis Research UK|NHS Lothian|NHS Grampian|NHS Tayside|NHS Borders|NHS Fife | Rheumatoid Arthritis | 2010-04 | PHASE4 |
| NCT02115750 | Coherus Oncology, Inc.|Daiichi Sankyo Co., Ltd. | Rheumatoid Arthritis | 2014-05 | PHASE3 |
| NCT00201838 | Ohio State University Comprehensive Cancer Center|Immunex Corporation | Pancreatic Neoplasms|Adenocarcinoma | 2001-07 | PHASE1|PHASE2 |
| NCT01932372 | Pfizer | Rheumatoid Arthritis | 2013-07-26 | |
| NCT01690299 | Amgen | Psoriasis|Psoriatic Arthritis | 2012-10-01 | PHASE3 |
| NCT04254627 | Nova Southeastern University|RTI International|Miami VA Healthcare System | Gulf War Illness | 2021-09-24 | PHASE1 |
| NCT00298272 | Biogen|Hoffmann-La Roche|Genentech, Inc. | Rheumatoid Arthritis | 2006-05 | PHASE2 |
| NCT00353119 | Innovaderm Research Inc.|Amgen | Palmoplantaris Pustulosis | 2006-04 | PHASE3 |
| NCT07184853 | First Affiliated Hospital of Zhejiang University|The First Affiliated Hospital of Zhengzhou University|Tongji Hospital|Union Hospital, Tongji Medical College, Huazhong University of Science and Technology|The Children´s Hospital of Zhejiang University School of Medicine|Ruijin Hospital | Graft vs Host Disease | 2025-09-25 | NA |
| NCT03332719 | Gema Biotech S.A.|QUID Quality in Drugs and Devices Latin American Consulting SRL | Rheumatoid Arthritis | 2016-02 | PHASE3 |
| NCT01610947 | University Hospital, Montpellier | Spondyloarthritis | 2012-05-14 | NA |
| NCT00118287 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Secondary Myelodysplastic Syndromes | 2005-04 | PHASE1|PHASE2 |
| NCT00093366 | Fred Hutchinson Cancer Center|National Cancer Institute (NCI) | Leukemia|Myelodysplastic Syndromes|Myelodysplastic+Myeloproliferative Diseases | 2004-06 | PHASE1|PHASE2 |
| NCT02638896 | Zhixiang Huang | Ankylosing Spondylitis | 2016-01 | PHASE4 |
| NCT01421069 | Pfizer | Juvenile Idiopahtic Arthritis | 2011-10-10 | PHASE3 |
| NCT00035958 | Children´s Hospital Medical Center, Cincinnati|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Immunex Corporation | Dermatomyositis | 2002-08 | PHASE2|PHASE3 |
| NCT03997786 | Sun Pharmaceutical Industries Limited | Moderate-to-severe Chronic Plaque Psoriasis | 2020-01-15 | PHASE2|PHASE3 |
| NCT00639717 | University of Michigan Rogel Cancer Center|Mallinckrodt|Amgen | Graft Versus Host Disease | 2009-03 | PHASE2 |
| NCT01294397 | Amgen | Postmenopausal|Osteopenia|Rheumatoid Arthritis|Osteoporosis | 2011-03 | PHASE1 |
| NCT00585650 | University of California, Irvine|Amgen | Psoriasis | 2007-05 | PHASE1|PHASE2 |
| NCT00224874 | National Heart, Lung, and Blood Institute (NHLBI)|National Cancer Institute (NCI)|Blood and Marrow Transplant Clinical Trials Network | Graft vs Host Disease|Immune System Disorders | 2005-09 | PHASE2 |
| NCT01241591 | Pfizer | Psoriasis | 2010-11 | PHASE3 |
| NCT00418717 | Wyeth is now a wholly owned subsidiary of Pfizer | Arthritis, Rheumatoid | 2007-02 | PHASE3 |
| NCT01303874 | University of Leeds | Rheumatoid Arthritis|Inflammatory Arthritis | 2006-09 | PHASE4 |
| NCT00110903 | Amgen | Rheumatoid Arthritis | | PHASE3 |
| NCT01009879 | University of Pittsburgh|Amgen | Rheumatoid Arthritis | 2009-11 | PHASE4 |
| NCT02701205 | Shanghai Celgen Bio-Pharmaceutical Co.,Ltd | Plaque Psoriasis|Psoriasis | 2015-01 | PHASE3 |
| NCT01068353 | University of Southampton|Hampshire Hospitals NHS Foundation Trust|Wyeth is now a wholly owned subsidiary of Pfizer | Alzheimer´s Disease | 2011-01 | PHASE2 |
| NCT01372930 | Xijing Hospital | Myocardial Infarction | 2010-04 | PHASE4 |
| NCT02840175 | Assistance Publique - H?pitaux de Paris|URC-CIC Paris Descartes Necker Cochin | Juvenile Idiopathic Arthritis | 2017-05-18 | PHASE3 |
| NCT00393471 | Wyeth is now a wholly owned subsidiary of Pfizer | Active Rheumatoid Arthritis | 2000-10 | PHASE3 |
| NCT01289743 | Charite University, Berlin, Germany|Rheumazentrum Ruhrgebiet | Ankylosing Spondylitis | 2002-02 | PHASE2 |
| NCT01053819 | University of Alabama at Birmingham|Amgen | Psoriasis|Melanoma|Non-melanoma Skin Cancer | 2007-09 | PHASE4 |
| NCT06011889 | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland|Medical Research Agency, Poland | SAPHO Syndrome | 2024-09-04 | PHASE2|PHASE3 |
| NCT02713997 | University of Minnesota|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Pancreatitis, Chronic; Diabetes; Transplant | 2016-12 | PHASE4 |
| NCT01592292 | Hoffmann-La Roche | Rheumatoid Arthritis | 2011-11 | |
| NCT00992394 | Pfizer | Psoriasis | 2010-01 | PHASE4 |
| NCT03451851 | Janssen Research & Development, LLC | Psoriasis | 2018-07-11 | PHASE3 |
| NCT00099554 | Amgen | Rheumatoid Arthritis | 2004-05 | PHASE4 |
| NCT03504072 | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Spondyloarthritis | 2018-01-16 | PHASE4 |
| NCT01295151 | Julia Brown | Rheumatoid Arthritis | 2011-08 | PHASE4 |
| NCT02322580 | Universitaire Ziekenhuizen KU Leuven|Pfizer | Psoriasis | 2015-01 | |
| NCT00503503 | Wyeth is now a wholly owned subsidiary of Pfizer | Rheumatoid Arthritis | 2005-03 | |
| NCT00488475 | Pfizer | Rheumatoid Arthritis | 2006-09 | |
| NCT01543204 | Amgen | Psoriasis | 2012-02-01 | PHASE4 |